Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ji-Feng Wu
The Safety and Efficacy of Amrubicin in the Treatment of Previously Untreated Extensive-Disease Small-Cell Lung Cancer: A Meta-Analysis
OncoTargets and Therapy
Oncology
Pharmacology
Related publications
The Efficacy of Amrubicin Third‐line Chemotherapy in Patients With Relapsed Extensive‐disease Small‐cell Lung Cancer: A Retrospective and Historical Study in a Single Institute
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
P2.01-29 Economic Analysis of Osimertinib in Previously Untreated EGFR-Positive Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy for Previously Untreated Metastatic Non-Small Cell Lung Cancer in the USA
BMJ Open
Medicine
Comparative Efficacy of Treatments for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer (Nsclc): A Network Meta-Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
P1.12-02 Phase II Study of Amrubicin Monotherapy in Elderly or Poor-Risk Patients With Extensive Disease of Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Pcn44 - First-Line Treatment Efficacy in Egfr-Positive Non-Small Cell Lung Cancer: A Network Meta-Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Clinical Efficacy and Safety of Afatinib in the Treatment of Non-Small-Cell Lung Cancer in Chinese Patients
OncoTargets and Therapy
Oncology
Pharmacology
The Prognostic Role of Circulating CD8+ T Cell Proliferation in Patients With Untreated Extensive Stage Small Cell Lung Cancer
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Efficacy and Safety of Icotinib in Treating Non-Small Cell Lung Cancer: A Systematic Evaluation and Meta-Analysis Based on 15 Studies
Oncotarget
Oncology
